3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride | CAS:817169-86-1

We serve 3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride CAS:817169-86-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride

Chemical Name:3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride
CAS.NO:817169-86-1
Synonyms:3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride
3-AMINO-4-CYCLOBUTYL-2-OXOBUTANAMIDE HCL
 
Physical and Chemical Properties:
Molecular Formula C8H15ClN2O2
Molecular Weight 206.67000
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Boceprevir(CAS:394730-60-0).



Contact us for information like 3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-AMINO-4-CYCLOBUTYL-2-OXOBUTANAMIDE HCL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride Use and application,3-AMINO-4-CYCLOBUTYL-2-OXOBUTANAMIDE HCL technical grade,usp/ep/jp grade.


Related News: Dr Maria Van Kerkhove, of the WHO’s emerging diseases unit, says it is important that you keep up basic hand and respiratory hygiene, such as washing your hands with soap and water and sneezing into your elbow or a tissue.5-Amino-1,3,4-thiadiazole-2-thiol manufacturer An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug.Diethyl 2,3-dichlorobutanedioate supplier The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.2-nitro-1-N-phenylbenzene-1,4-diamine vendor The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.